Company / EPS (Diluted)
VitaNova Life Sciences Corp EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.01
FY2025
5-year range
-$0.01 / $0.02
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 7 years, ranging from $-0.01 in FY2022 to $0.02 in FY2023.
Based on SEC 10-K filings.
0.01 in FY2025.
Declined from $0.02 to $0.01 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.02 | +300.0% |
| FY2022 | -$0.01 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026